{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0008283",
      "entity_text" : "proliferation",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P29279",
      "entity_text" : "CTGF",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Treatment of primary osteoblasts or osteoblastic cell lines (Saos-2 or MC3T3-E1) with recombinant CTGF stimulates proliferation, matrix production, mineralization, and up-regulates the expression of markers of osteoblast differentiation including type I collagen, osteopontin, osteocalcin and alkaline phosphatase [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-07-28T16:47:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T16:38:39Z",
  "trigger" : "stimulates",
  "evidence" : [ "CTGF stimulates proliferation" ],
  "pmc_id" : "4340870",
  "score" : 0
}